TCM Biotech International Corp. (TPE:4169)
Taiwan · Delayed Price · Currency is TWD 270.00
-9.00 (-3.23%)
At close: Jul 9, 2026
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 15.94 billion as of July 9, 2026. Its market cap has increased by 392.70% in one year.
Market Cap
15.94B
Enterprise Value
15.37B
Revenue
703.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
270.00
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 15.94B, an increase of 1,065.43%. That is a compound annual growth rate of 18.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 15.94B | 56.07% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 12.80B |
| Taho Pharmaceuticals | 6.02B |
| Libo Pharma | 2.26B |
| TEH SENG Pharmaceutical Mfg. | 2.15B |
| Anbogen Therapeutics | 1.98B |
| Timing Pharmaceutial | 1.73B |
| Anya Biopharm | 1.67B |
| TSA International | 1.60B |